In the debate over the economic stimulus bill, it seemed like all politicians wanted to talk about was “shovel-ready” infrastructure projects. Congress’s love for roads and bridges notwithstanding, lawmakers did include a significant chunk of money for “shovel-ready” scientific research. The National Institute of Allergy and Infectious Diseases will get $1.12 billion from […]
HIV
With a matter-of-fact and unanimous approval of the PEPFAR Extension Act of 2018, a five-year renewal of the U.S. flagship program to combat HIV globally, the […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The report on outcomes of measles elimination efforts released last week by the World Health Organization and the U.S. Centers for Disease Control and Prevention shows, […]